IDEXX Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,446	4,304	3,898	3,661	3,367	3,215
Revenue Growth (YoY)	13.08%	10.42%	6.46%	8.72%	4.73%	18.79%
Cost of Revenue	1,687	1,644	1,519	1,471	1,363	1,326
Gross Profit	2,759	2,660	2,379	2,190	2,004	1,889
Selling, General & Admin	1,095	1,048	1,031	901.89	850.75	796.4
Research & Development	257.93	251.21	219.79	190.95	254.82	161.01
Total Operating Expenses	1,353	1,300	1,251	1,093	1,106	957.4
Operating Income	1,406	1,360	1,128	1,097	898.77	932.03
Interest Income	2.39	3.01	12.7	5.63	1.07	0.43
Interest Expense	-38.93	-38.85	-31.21	-41.58	-39.86	-29.81
Total Non-Operating Income (Expense)	-36.54	-35.84	-18.51	-35.95	-38.79	-29.37
Pretax Income	1,370	1,324	1,110	1,061	859.97	902.65
Provision for Income Taxes	274.31	264.73	221.96	216.13	180.88	157.81
Net Income	1,095	1,059	887.87	845.04	679.09	744.85
Minority Interest in Earnings	-	-	-	-	-	-0
Net Income to Common	1,095	1,059	887.87	845.04	679.09	744.85
Net Income Growth	22.38%	19.33%	5.07%	24.44%	-8.83%	28.03%
Shares Outstanding (Basic)	80	80	82	83	84	85
Shares Outstanding (Diluted)	81	81	83	84	85	87
Shares Change (YoY)	-2.60%	-2.67%	-0.87%	-0.73%	-2.28%	-0.17%
EPS (Basic)	13.70	13.17	10.77	10.17	8.12	8.74
EPS (Diluted)	13.58	13.08	10.67	10.06	8.03	8.60
EPS Growth	25.51%	22.59%	6.06%	25.28%	-6.63%	28.17%
Shares Outstanding	79.24	79.71	81.6	83.03	82.89	84.56
Free Cash Flow	1,083	1,057	808.08	772.88	394.15	636
Free Cash Flow Growth	2.49%	30.82%	4.55%	96.09%	-38.03%	17.54%
Free Cash Flow Per Share	13.45	13.05	9.71	9.20	4.66	7.35
Gross Margin	62.05%	61.80%	61.04%	59.82%	59.52%	58.76%
Operating Margin	31.63%	31.60%	28.95%	29.97%	26.69%	28.99%
Profit Margin	24.63%	24.62%	22.78%	23.08%	20.17%	23.17%
FCF Margin	24.37%	24.56%	20.73%	21.11%	11.71%	19.78%
EBITDA	1,555	1,505	1,258	1,212	1,011	1,037
EBITDA Margin	34.97%	34.97%	32.28%	33.11%	30.01%	32.24%
EBIT	1,406	1,360	1,128	1,097	898.77	932.03
EBIT Margin	31.63%	31.60%	28.95%	29.97%	26.69%	28.99%
Effective Tax Rate	20.03%	19.99%	20.00%	20.37%	21.03%	17.48%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q